Skip to main content

Ransomware victim disclosure

All victims

Duo Pharma Biotech

listed as duopharmabiotech.com · Claimed by ValenciaLeaks · listed 2 years ago

25.7 GB
Data size
22m
Age
since listed · data leaked

Status timeline

  1. ListedSep 18, 2024
  2. Data leakeddate unknown

At a glance

Status
Data leaked
Country
Malaysia
Listed on leak site
Sep 18, 2024
Data size
25.7 GB

About the victim

AI dossier — public-source company profile

Duo Pharma Biotech is a pharmaceutical and biotechnology company operating under the domain duopharmabiotech.com. Limited public information is available due to the site requiring JavaScript for access.

Industry
Pharmaceutical & Biotechnology

Attack summary

Severity: high — Confirmed exfiltration of 25.7 GB of data from a pharmaceutical company. Healthcare sector data carries regulatory significance (HIPAA, GDPR, etc.) and the large data volume suggests material business and potentially patient information exposure.

ValenciaLeaks claims to have exfiltrated 25.7 GB of data from Duo Pharma Biotech on 23 August 2024. The group has published the data; specific details on data contents and encryption status are not provided in the available post excerpt.

high

Data the group says was taken

AI dossier — extracted from the leak post
  • Company files and databases
  • Unspecified sensitive business data

What the group claims

Data Exfiltrated : 25.7GB - Leak Date : 23.08.2024:04:00

Sources

Source

Indexed 2 years ago

This page surfaces a public ransomware disclosure indexed by Darkfield. Original posts come from the operator's own leak site; we cross-check against ransomware.live, RansomLook and RansomWatch where applicable. Share this URL freely.

Is this your supplier? Your competitor? You?

Pro plans monitor your domain, corporate emails, and crypto wallets across every new ransomware leak-site post, breach dump and Telegram callout — alerts within 5 minutes.

Disclosure context

About ValenciaLeaks

ValenciaLeaks is a recently emerged ransomware group first observed in September 2024, operating with apparent financial motivations and targeting a diverse range of sectors across multiple countries. The group's origin and affiliations remain largely undocumented by major cybersecurity organizations, though their targeting pattern suggests a geographically diverse operational scope spanning the United States, Malaysia, Luxembourg, Bangladesh, and Spain. Based on limited available intelligence, ValenciaLeaks appears to focus on opportunistic targeting across business services, healthcare, manufacturing, and government sectors, with at least five confirmed victims documented since their emergence. The group's specific attack methodologies, including initial access vectors, encryption techniques, and whether they employ data exfiltration tactics prior to encryption, have not been comprehensively analyzed or reported by established threat intelligence sources such as CISA, FBI, or major security research organizations. No major high-profile campaigns, significant ransom demands, or law enforcement disruption activities have been publicly documented regarding this group. The current operational status of ValenciaLeaks remains unclear due to the limited public intelligence available, though their recent emergence suggests they may still be in early operational phases. The group has been linked to 5 public disclosures across our corpus. First observed on a leak site on September 10, 2024; most recent post September 18, 2024. The operation is currently inactive.

Also tracked as: valencia leaks.

Timeline of this disclosure

  • September 18, 2024duopharmabiotech.com listed by ValenciaLeakson the group's public leak site
Data size
25.7 GB

Sector and geography

This disclosure adds to ransomware activity in the Healthcare sector, which has 2,600 disclosures indexed across all operators we track. Geographically, duopharmabiotech.com is reported in Malaysia, a country with 40 ransomware disclosures in our corpus.

If your organisation is affected

A listing by ValenciaLeaks means duopharmabiotech.com appeared on a ransomware extortion site and data attributed to it has been published. If this is your organisation, or a supplier you depend on, the priority is to confirm the intrusion and contain it before the window to act closes.

  • Engage your incident-response team and preserve forensic evidence before remediating — do not wipe affected systems first.
  • Force a password reset and revoke active sessions for exposed accounts; rotate any credentials, API keys or certificates that may have been in the stolen data.
  • Assess regulatory notification duties (GDPR, NIS2, sector regulators) — many carry a 72-hour reporting clock from awareness.
  • Monitor for the data appearing on ValenciaLeaks's leak site and across paste and breach channels, and brief downstream partners who may be exposed through you.

How we know this. Darkfield monitors public ransomware leak sites continuously, archiving every new disclosure and the data later released against the victim. Each entry on this page is sourced from the operator's own publication and cross-checked against complementary OSINT feeds (RansomLook, ransomware.live, RansomWatch). We do not collect or host stolen data — only the metadata, timestamps and screenshots needed to make the public disclosure searchable and accountable. Records here are corrected when the original post is edited, retracted, or merged with another disclosure.